D-ABFT Study Guide: Interpreting, Not Just Memorizing

The defining difficulty in forensic toxicology is interpretive: the science requires you to attach defensible meaning to a concentration measured in a specific matrix, by a specific method, under specific kinetic assumptions. Memorizing half-lives and validation parameters is necessary but not sufficient. The study approach that fits this exam is to pair every named concept with a decision rule, then rehearse that rule on paper cases where the tempting conclusion is wrong. Work each scenario below, write your interpretation first, and score it against the rubric before reading the resolution.

First-order versus Michaelis-Menten kinetics: which model fits the case?

First-order elimination removes a constant fraction of drug per unit time, so the half-life is constant. Michaelis-Menten (saturable) elimination uses a finite capacity, so small dose or timing changes can produce disproportionate concentration changes.

Distinguish the two models by their behavior, not their labels. Under first-order kinetics, doubling the dose roughly doubles the concentration and the decline curve is exponential with a fixed half-life. Under saturable kinetics, elimination approaches a maximum rate, so at high concentrations the process behaves almost zero-order: concentration falls by a nearly fixed amount per hour, and the apparent half-life lengthens as concentrations rise. Ethanol at elevated levels and several anticonvulsants are classic teaching examples where saturable behavior matters.

Apply the distinction as a back-extrapolation check. If a case requires estimating a drug concentration at an earlier time, first decide whether constant-fraction math is defensible or whether capacity-limited elimination makes a straight-line segment the better assumption. Then state the assumption explicitly in your interpretation, because an extrapolation built on the wrong model can overstate or understate the estimate dramatically. Practice this by sketching both decline curves for the same starting concentration and asking which curve the case data actually support.

• First-order: constant fraction eliminated per unit time; log concentration declines linearly.
• Saturable (Michaelis-Menten): elimination rate approaches a maximum; apparent half-life varies with concentration.
• Decision rule: never back-extrapolate until you have declared which model you are assuming.

Screening versus confirmation: what each result can and cannot support

Immunoassay screens detect a drug class quickly but can cross-react with unrelated compounds. GC-MS and LC-MS/MS confirm identity through retention time plus mass spectra or ion ratios, so interpretive weight should match the method tier.

Treat every screening result as a hypothesis, not a finding. An immunoassay responds to structural similarity across an entire class, which is why cross-reactivity with structurally related compounds, or a negative screen despite a drug present below the assay cutoff, is a real interpretive category rather than an edge case. Confirmatory methods answer a different question: which specific compound, at approximately what concentration, in which matrix, measured against validated criteria such as ion-ratio tolerances and calibrator ranges.

Carry this distinction into how you would phrase a report. A screen-only positive supports cautious language such as presumptive detection pending confirmation; a confirmed, quantitated result supports comparison and interpretation, but only within the method's validated scope. Know the validation concepts that gate that scope: limit of detection versus limit of quantitation, matrix effects, carryover, and the calibrated range. If a reported concentration falls outside the calibrated range, your written interpretation should say so rather than treating the number as if it were fully quantitative.

• Screening: fast, class-wide, vulnerable to cross-reactivity and false negatives near the cutoff.
• Confirmation: compound-specific identity plus quantitation, bounded by validation and calibration.
• Report language should always reveal which tier produced the result.

Postmortem redistribution: why central blood can mislead you

Postmortem redistribution (PMR) is the diffusion of drugs after death, often from tissue depots into nearby blood. Central blood frequently exceeds peripheral blood, so sampling site and case context govern interpretation.

The mechanism matters more than the slogan. After circulation stops, concentration gradients drive drugs out of organs and tissues where they accumulated in life, and cardiac blood, sitting near the lungs, liver, and heart muscle, commonly shows higher levels than femoral blood. Drugs that are extensively distributed to tissue are the classic subjects of PMR discussion in the literature. The practical consequence is that a central-blood concentration cannot be read against an antemortem therapeutic range as if the two were equivalent measurements.

Worked scenario 1: a death investigation reports fentanyl at roughly 45 ng/mL in heart blood and about 6 ng/mL in femoral blood. The tempting conclusion is a massive overdose based on the cardiac number. The better decision is to report both values with their sites identified, note the postmortem redistribution potential of the drug, and weigh the concentration together with route-of-administration evidence, scene findings, and autopsy observations. Why it matters: anchoring the conclusion to the highest available number can overstate the case, and a defensible interpretation survives cross-examination precisely because it says what each number can and cannot establish.

• PMR direction: tissue depot toward blood, so site-to-site differences are expected, not anomalies.
• Decision rule: every blood concentration in a report is identified with its anatomical site.

Antemortem ingestion or postmortem change: ethanol and unstable drugs

Ethanol can be produced microbially after death, and cocaine hydrolyzes to benzoylecgonine. Comparing multiple matrices, especially vitreous humor against blood, helps separate drinking before death from synthesis after it.

Postmortem ethanol synthesis arises when glucose and other substrates meet microorganisms in decomposing tissue, so elevated blood ethanol alone cannot distinguish antemortem ingestion from production after death. The classic interpretive pattern compares ethanol across vitreous humor, urine, and blood: broadly consistent values across fluids support ingestion before death, while a low vitreous value against a high blood value raises the possibility of postmortem synthesis. Vitreous humor is comparatively sheltered from bacterial activity, which is exactly why the comparison carries weight.

Cocaine presents the mirror-image problem: it disappears rather than appears. Cocaine continues hydrolyzing to benzoylecgonine after collection unless samples are handled and stored appropriately, so a specimen showing benzoylecgonine with little or no cocaine may reflect either earlier elimination in life or ongoing degradation. Apply the same discipline in both cases: describe the direction of possible change, identify which matrices support which reading, and let the multi-fluid pattern, not any single number, drive the conclusion.

• Synthesis check: low vitreous ethanol with high blood ethanol raises the postmortem-production question.
• Degradation check: cocaine-to-benzoylecgonine patterns must be read with storage conditions in mind.
• Decision rule: state the direction of possible postmortem change before interpreting any single value.

Human performance toxicology: presence is not impairment

Human performance toxicology asks whether a drug could have impaired driving or work performance. Detection establishes exposure; impairment requires linking concentration, timing, the drug's effects, and individual factors such as tolerance.

Keep three ideas separate: exposure, recency, and impairment. A positive urine result establishes that a drug or metabolite was excreted at some point, which may span days to weeks for some substances; a blood concentration speaks more directly to recent exposure; neither alone establishes that the person was functionally impaired at a specific moment. Impairment opinions additionally rest on the drug's known effects, the plausibility of residual effects, and observed behavior, and some jurisdictions impose per se or zero-tolerance rules for specific drugs that operate differently from impairment-based standards.

Worked scenario 2: a driver in a collision has urine positive for the cannabis metabolite carboxy-THC, and the report is drafted as evidence of recent use and impairment. The mistake is collapsing all three ideas into one. The better decision is to explain that carboxy-THC's detection window extends well beyond the period of acute effects, request or rely on blood data where available, and base any impairment statement on blood concentrations together with the driving observations. Why it matters: a urine metabolite can be positive long after impairment is impossible, and an interpretation that ignores that window is not defensible in testimony.

• Exposure vs. recency vs. impairment: three questions, three different evidence bases.
• Statutory per se rules for some drugs differ from impairment-based conclusions; do not blend them.
• Decision rule: for every impairment-adjacent conclusion, name the matrix and the recency limits of that matrix.

Chain of custody and courtroom language: keeping opinions defensible

Every conclusion must be traceable to documented specimen handling and to the validated limits of the method. Qualified language, stated uncertainty, and opinions drawn strictly from data keep testimony within defensible bounds.

Custody is the interpretive foundation, not paperwork overhead. Sealed containers, documented transfers, and recorded storage conditions are what allow you to connect the number on the report to the specimen from the person. Storage conditions also interact with analyte stability, as the cocaine hydrolysis example shows, so custody records and stability considerations are read together. When handling cannot be documented, the honest position is that the analytical result cannot be linked to the case material, whatever the instrument says.

On testimony, constrain your language to what the method validated. Opinion terms should be calibrated: findings are consistent with a scenario, or cannot exclude one, rather than proving it, and quantitative claims stay inside the calibrated range with uncertainty acknowledged. Ethical obligations in forensic practice run the same direction: conclusions must be derived from the data and documented method, and separation between examination development and certification decisions is a principle the ABFT states for its own program, which signals the field's broader insistence on impartiality.

• Custody chain, sealing, and storage records are interpretive evidence, not clerical extras.
• Calibrated opinion language: consistent with, cannot exclude, within the limits of the validated method.
• Decision rule: before any conclusion, confirm the reported value sits inside the method's validated scope.

A four-week drill plan with a self-check rubric

Run a four-week sequence: pharmacokinetics and interpretation drills, analytical method decision practice, postmortem and human performance case simulations, then mixed timed sets. Score every written interpretation against a fixed rubric.

Adapt this sequence to the time you have. Week one: work kinetics problems until you can classify a case as first-order or saturable on sight and write the back-extrapolation assumption in one sentence. Week two: for each analytical scenario, write which tier (screen or confirm) supports which statement, plus one validation limitation that bounds the claim. Week three: simulate postmortem and human performance cases, including the two scenarios above, and rewrite each conclusion with site identifiers and recency limits. Week four: mix all domains in timed sets and grade every answer with the rubric below.

Practical exercise with expected observations: take a paper case of a fentanyl-related death with cardiac and femoral values, plus a norfentanyl finding. Before reading any resolution, write a five-sentence interpretation. A strong answer shows the following observable features: it labels each concentration with its anatomical site; it names the kinetic or redistribution concept it is invoking; it separates detection from any statement about cause or impairment; it identifies at least one limitation of the method or matrix; and it avoids comparing postmortem values to antemortem therapeutic ranges without a caveat. Read your answer against those five checkpoints and mark each met or not met.

• Self-check rubric: sampling site named; concept named; detection separated from impairment or cause; method or matrix limitation stated; no uncaveated comparison to therapeutic ranges.
• Scoring: five of five met means the interpretive habit is in place; treat rubric scores as learning milestones, not as predictions of your exam performance.
• Readiness check 1: you can resolve both worked scenarios above without re-reading them.
• Readiness check 2: you can state, from memory, one thing each matrix in the table can and cannot support.
• Readiness check 3: every practice interpretation you write now contains an explicit assumption statement.

References and further reading

Use these references to explore the concepts and check the latest information from the relevant organizations.

• abft.org

Continue your preparation

• American Board Of Forensic Toxicology Diplomate Forensic Toxicology D Abft
• Study Guides